Spire Healthcare Group (LSE:SPI) reported trading in the first four months of 2026, covering 1 January to 30 April, was in line with expectations and reconfirmed its FY26 outlook ahead of its AGM later today.
The UK independent healthcare group, which operates 38 hospitals and over 60 clinics, said private patient revenue continued to grow strongly-particularly self-pay-while NHS revenue was in line with expectations.
NHS commissioning plans reset in April 2026 for Spire's Q2-Q4 FY26 and Q1 FY27, with more than 85% of commissioning agreed and volumes said to align with prior guidance, indicating strong growth into Q1 FY27 supported by a lower Q1 FY26 base.
Management reported that delivery of the FY26 £30m efficiency savings target is progressing well with the majority of initiatives underpinned and that Primary Care and integrated referral activity continue to trade positively.
"The Group continues to target FY26 Group adjusted EBITDA broadly in line with FY25," the company said.
